How to build a Custom mRNA Program Using Outsourcing Services

Overview

A demand has been created for experts capable of producing mRNA. This paper discusses what biopharma companies exploring mRNA treatments should look for in their CDMO, and key considerations for evaluating and using outsourcing partners for mRNA development and mRNA manufacturing.

Key Takeaways

• An overview of the global mRNA market

• What developers should look for in an mRNA outsourcing partner

• CDMO selection strategies for both large pharma and small developers

•  The impact of partners with global reach